Transplantation · 2012 · 78 citations · 18 references
MedicineOncologyCancer EpidemiologyHepatologyTransplant SurgeryHepatobiliary CancerHepatocellular CarcinomaLiver CancerLiver TransplantationMalignant NeoplasmsMetabolic SyndromeHazard Ratio ModelingHepatocellular Carcinoma TransplantationLow Body Mass IndexMetabolic Complications After TransplantationObesity-related Cancer RiskOverall MortalityVascular Invasion AssessmentVascular Invasion Prognosis
UNLABELLED: For many cancers, features of the metabolic syndrome, such as diabetes and obesity, have been associated with both increased risk of cancer development and poor outcomes. METHODS: We examined a large retrospective cohort of 342 consecutive patients who underwent liver transplantation for hepatocellular carcinoma between January 1999 and July 2010 at our institution. We evaluated the relationship between diabetes, obesity, hepatocellular carcinoma (HCC) recurrence, and overall survival. RESULTS: We found that a body mass index (BMI) higher than 30 was an independent predictor of poor overall survival in a multivariable Cox model, approximately doubling the risk of death after transplantation. A BMI higher than 30 was also a predictor of recurrent HCC, although this was of borderline statistical significance (hazard ratio for recurrence, 1.9; 95% confidence interval, 0.9-4.1). We also found increased BMI to be an independent predictor of microvascular invasion within HCC tumors, lending a possible explanation to these results. Those with diabetes showed worsened overall survival compared with those without diabetes in univariate but not multivariable analysis, possibly related to longer wait times. CONCLUSIONS: Our findings suggest a relationship between higher BMI, tumor vascular invasion, increased recurrence, and worsened overall survival. These findings may help explain why those with high BMI have worse outcomes from their cancers. A better understanding of the role of obesity and diabetes in patients with cancer should help develop better predictors of outcome and improved treatment options for patients with HCC.
18
Estimating the world cancer burden: Globocan 2000
D. Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · International Journal of Cancer · 2001 · 3.7K citations · Full text
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Hugh A. Edmondson, Paul E. Steiner · Cancer · 1954 · 2.8K citations